Stone X Group Inc. Theratechnologies Inc. Transaction History

Stone X Group Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 13, 2025	SELL	$0.78 - $1.01 $35 - $45	-45 Reduced 0.32%	14,000 $11.8 Million
Q1 2023 Aug 13, 2025	BUY	$0.72 - $1.12 $32 - $50	45 Added 0.32%	14,045 $11.4 Million
Q4 2022 Aug 13, 2025	BUY	$0.83 - $8.04 $11,620 - $112,559	14,000 New	14,000 $12.4 Million
Q3 2022 Aug 13, 2025	BUY	$1.98 - $2.42 $520 - $636	263 Added 1.87%	14,292 $33.9 Million
Q3 2022 Nov 08, 2022	SELL	$1.98 - $2.42 $57 - $70	-29 Reduced 0.21%	14,000 $33,000

Q2 2022 Aug 13, 2025	BUY	$2.21 - $2.7 $64 - $78	29 Added 0.21%	14,029 $31.8 Million
Q2 2022 Jul 27, 2022	BUY	$2.21 - $2.7 $64 - $78	29 Added 0.21%	14,029 $32,000
Q1 2022 Aug 13, 2025	BUY	$2.37 - $3.24 $33,180 - $45,360	14,000 New	14,000 $34.3 Million
Q1 2022 Aug 13, 2025	BUY	$2.37 - $3.24 $33,180 - $45,360	14,000 New	14,000 $34.3 Million
Q4 2021 Aug 13, 2025	BUY	$2.92 - $3.76 $40,880 - $52,640	14,000 New	14,000 $42,000
Q4 2019 Jan 24, 2020	BUY	$2.74 - $4.2 $38,360 - $58,800	14,000 New	14,000 $46,000

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $323M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

Stay updated on Stone X Group Inc. with notifications on news.